The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Enhancing the Enrichment of Pharmacophore-Based Target Prediction for the Polypharmacological Profiles of Drugs
Abstract
PharmMapper is a web server for drug target identification by reversed pharmacophore matching the query compound against an annotated pharmacophore model database, which provides a computational polypharmacology prediction approach for drug repurposing and side effect risk evaluation. But due to the inherent nondiscriminative feature of the simple fit scores used for prediction results ranking, the signal/noise ratio of the prediction results is high, posing a challenge for predictive reliability. In this paper, we improved the predictive accuracy of PharmMapper by generating a ligand-target pairwise fit score matrix from profiling all the annotated pharmacophore models against corresponding ligands in the original complex structures that were used to extract these pharmacophore models. The matrix reflects the noise baseline of fit score distribution of the background database, thus enabling estimation of the probability of finding a given target randomly with the calculated ligand-pharmacophore fit score. Two retrospective tests were performed which confirmed that the probability-based ranking score outperformed the simple fit score in terms of identification of both known drug targets and adverse drug reaction related off-targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Hopkins, A. L. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1110 · Cited by 1,242
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
A Survey of Recent Advances in Hierarchical Clustering Algorithms
Murtagh, F. (1983) · The Computer Journal · doi:10.1093/comjnl/26.4.354 · Cited by 1,058
Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., & Jiang, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq300 · Cited by 967
Self-citationSehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439 · Cited by 622
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
A robustness-based approach to systems-oriented drug design
Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488
Phase III and submission failures: 2007–2010
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3375 · Cited by 480
Polypharmacology – Foe or Friend?
Peters, J.-U. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400856t · Cited by 465
Easton, J. B., & Houghton, P. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209886 · Cited by 459
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 421
TarFisDock: a web server for identifying drug targets with docking approach
Li, H., Gao, Z., Kang, L., Zhang, H., Yang, K., Yu, K., Luo, X., Zhu, W., Chen, K., Shen, J., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl114 · Cited by 420
Self-citationWhy Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417
SIROLIMUS-ASSOCIATED PULMONARY TOXICITY
Pham, P.-T. T., Pham, P.-C. T., Danovitch, G. M., Ross, D. J., Gritsch, H. A., Kendrick, E. A., Singer, J., Shah, T., & Wilkinson, A. H. (2004) · Transplantation · doi:10.1097/01.tp.0000118413.92211.b6 · Cited by 298
Laufs, U., Gertz, K., Dirnagl, U., Böhm, M., Nickenig, G., & Endres, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02649-5 · Cited by 282
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTS
Morelon, E., Stern, M., Israel-Biet, D., Correas, J.-M., Danel, C., Mamzer-Bruneel, M.-F., Peraldi, M.-N., & Kreis, H. (2001) · Transplantation · doi:10.1097/00007890-200109150-00008 · Cited by 274
Rapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects
Sarro, A., & Sarro, G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373435 · Cited by 215
Gong, J., Cai, C., Liu, X., Ku, X., Jiang, H., Gao, D., & Li, H. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt270 · Cited by 211
Self-citationFluoroquinolone Antimicrobials: Singlet Oxygen, Superoxide and Phototoxicity
Martinez, L. J., Sik, R. H., & Chignell, C. F. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb05217.x · Cited by 202
Xie, L., Xie, L., Kinnings, S. L., & Bourne, P. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134630 · Cited by 202
Paeshuyse, J., Dallmeier, K., & Neyts, J. H. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.030 · Cited by 116
Patterns of Pulmonary Complications Associated with Sirolimus
Chhajed, P. N., Dickenmann, M., Bubendorf, L., et al. (2005) · Respiration · doi:10.1159/000087945 · Cited by 89
Li, Q., Rao, R. R., Vazzana, J., Goedegebuure, P. S., Odunsi, K. O., Gillanders, W. E., & Shrikant, P. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103365 · Cited by 89
Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach
AbdulHameed, M. D. M., Chaudhury, S., Singh, N. P., Sun, H., Wallqvist, A., & Tawa, G. J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2003544 · Cited by 84
???Extreme Duplication??? in the US FDA Adverse Events Reporting System Database
Hauben, M., Reich, L., DeMicco, J., & Kim, K. K. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00009 · Cited by 79
Drug profiling: knowing where it hits
Merino, A., Bronowska, A. K., Jackson, D., & Cahill, D. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.006 · Cited by 71
Drug Adverse Reaction Target Database (DART)
Ji, Z. L., Han, L., Yap, C. W., Sun, L., Chen, X., & Chen, Y. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00002 · Cited by 64
Calcineurin inhibitors and rapamycin: cancer protection or promotion?
Weischer, M., Röcken, M., & Berneburg, M. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00555.x · Cited by 63
3D pharmacophores as tools for activity profiling
Schuster, D. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.11.006 · Cited by 61
Liu, X., Bai, F., Ouyang, S., Wang, X., Li, H., & Jiang, H. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-101 · Cited by 58
Self-citationFlexible 3D pharmacophores as descriptors of dynamic biological space
Nettles, J. H., Jenkins, J. L., Williams, C., Clark, A. M., Bender, A., Deng, Z., Davies, J. W., & Glick, M. (2007) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.02.005 · Cited by 51
Bougie, I., & Bisaillon, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308917200 · Cited by 44
Rollof, J., & Vinge, E. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700909 · Cited by 41
S-adenosyl-L-homocysteine: A non-cytotoxic hypomethylating agent
Cabo, S. F. D., Hazen, M. J., Molero, M. L., & Fernández‐Piqueras, J. (1994) · Cellular and Molecular Life Sciences · doi:10.1007/bf01952867 · Cited by 27
Gobbi, G., & Janiri, L. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00055-3 · Cited by 25
Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
Reddy, A. S., Tan, Z., & Zhang, S. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500092j · Cited by 20
Polypharmacological Kinase Inhibitors: New Hopes for Cancer Therapy
Petrelli, A. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch8 · Cited by 13
Cited by
Wang, X., Shen, Y., Wang, S., Li, S., Zhang, W., Liu, X., Lai, L., Pei, J., & Li, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx374 · Cited by 1,588
Self-citationArtificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Zeng, Q., Nie, X., Li, L., Liu, H.-F., Peng, Y.-Y., Zhou, W.-T., Hu, X.-J., Xu, X.-Y., & Chen, X.-L. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.1c00950 · Cited by 33
Guo, G., & Dong, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2068755 · Cited by 17
Metadata
- Authors
- Wang, X., Pan, C., Gong, J., Liu, X., & Li, H.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-05-31
- Volume
- 56
- Issue
- 6
- Pages
- 1175-1183
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2407564830
- Cited by
- 290
- References
- 48
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.